Everolimus-Based Immunosuppression in Liver Transplant Recipients

被引:2
|
作者
Saliba, F. [1 ]
机构
[1] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, INSERM,Unite 1193, Villejuif, France
关键词
D O I
10.1111/ajt.14388
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:2489 / 2489
页数:1
相关论文
共 50 条
  • [1] Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie-Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Boillot, Olivier
    Giostra, Emiliano
    Dumortier, Jerome
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : 660 - 669
  • [2] CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS.
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Boillot, Olivier
    Giostra, Emiliano
    Dumortier, Jerome
    LIVER TRANSPLANTATION, 2009, 15 (07) : S245 - S246
  • [3] Impact of Everolimus-based Immunosuppression on Renal Function in Liver Transplant Recipients
    Nogueras Lopez, Flor
    Abellan Alfocea, Patricia
    Ortega Suazo, Eva Julissa
    Lopez Garrido, Maria Angeles
    Becerra Massare, Antonio
    Gila Medina, Ana Maria
    Redondo Cerezo, Eduardo
    Espinosa Aguilar, M. Dolores
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (02) : 556 - 558
  • [4] Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience
    Εvangelos Cholongitas
    Ioannis Goulis
    Eleni Theocharidou
    Nikolaos Antoniadis
    Ioannis Fouzas
    Dimitrios Giakoustidis
    George Imvrios
    Olga Giouleme
    Vasilios Papanikolaou
    Evangelos Akriviadis
    Themistoklis Vasiliadis
    Hepatology International, 2014, 8 : 137 - 145
  • [5] Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience
    Cholongitas, Evangelos
    Goulis, Ioannis
    Theocharidou, Eleni
    Antoniadis, Nikolaos
    Fouzas, Ioannis
    Giakoustidis, Dimitrios
    Imvrios, George
    Giouleme, Olga
    Papanikolaou, Vasilios
    Akriviadis, Evangelos
    Vasiliadis, Themistoklis
    HEPATOLOGY INTERNATIONAL, 2014, 8 (01) : 137 - 145
  • [6] Influence of Everolimus-Based Immunosuppression on Infections in Heart Transplant Recipients
    Ohdah, S.
    Meyer, S.
    Schlueter, M.
    Deuse, T.
    Muellerleile, K.
    Reichenspurner, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S190 - S190
  • [7] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530
  • [8] Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression
    Buerker, B. S.
    Malt, U. F.
    Gude, E.
    Gullestad, L.
    Relbo, A.
    Grov, I.
    Andreassen, A. K.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S288 - S289
  • [9] Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
    Manzia, T. M.
    Angelico, R.
    Toti, L.
    Grimaldi, C.
    Sforza, D.
    Vella, I.
    Tariciotti, L.
    Lenci, I.
    Breshanaj, G.
    Baiocchi, L.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 175 - 183
  • [10] Predicting Adverse Events in Liver Transplant Patients on Everolimus-Based Immunosuppression
    De Simone, Paolo
    Carrai, Paola
    Coletti, Laura
    Precisi, Arianna
    Ghinolfi, Davide
    Filipponi, Franco
    TRANSPLANTATION, 2016, 100 : S227 - S227